SCHEMBL1369733

SCHEMBL1369733

c1ccc2c(c1)ccn1c3ccccc3nc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.46
ALDH1A1 P00352 7/20 0.46
LMNA P02545 4/20 0.46
TP53 P04637 3/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
NPC1 O15118 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
PARP1 P09874 1/20 0.45
MAPT P10636 5/20 0.45
HSD17B10 Q99714 3/20 0.45
POLB P06746 2/20 0.45
PTPN2 P17706 1/20 0.44
PTPN1 P18031 1/20 0.44
PRKDC P78527 4/20 0.44
HPGD P15428 5/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17075238 0.82 RAD51 (0.44) KDM4EALDH1A1LMNATP53SMN1; SMN2
SCHEMBL14815466 0.82 RAD51 (0.44) KDM4EALDH1A1LMNATP53SMN1; SMN2
SCHEMBL12145464 0.82 IDO1 (0.45) KDM4EALDH1A1TP53SMN1; SMN2NPC1
SCHEMBL17075173 0.82 IDO1 (0.41) KDM4EALDH1A1TP53SMN1; SMN2NPC1
SCHEMBL29484665 0.80 KDM4E (0.48) KDM4EALDH1A1LMNATP53SMN1; SMN2
SCHEMBL12145438 0.80 IKBKB (0.51) KDM4EALDH1A1TP53SMN1; SMN2NPC1
SCHEMBL12145440 0.80 MAPT (0.47) KDM4EALDH1A1TP53SMN1; SMN2PARP1
SCHEMBL14127581 0.80 PRKDC (0.42) ALDH1A1TP53SMN1; SMN2PARP1MAPT
SCHEMBL12145459 0.80 PRKDC (0.42) KDM4EALDH1A1TP53SMN1; SMN2PARP1
SCHEMBL14232581 0.80 PRKDC (0.42) KDM4EALDH1A1TP53SMN1; SMN2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930614-A Benzo [4,5] imidazo [2,1-a ] isoquinoline compound and preparation method and application thereof 烟台大学 2025-05-06 CN claimed
CN-118930483-A Synthesis method of isoquinolone selenocyanate 新疆大学 2024-11-12 CN claimed
CN-116789664-A Method for synthesizing benzoimidazole isoquinoline analogue containing trifluoromethyl 长沙理工大学 2023-09-22 CN claimed
CN-113698399-B Isoquinoline compound and preparation method and application thereof 浙江省人民医院 2022-05-27 CN claimed
EP-2872506-A1 METHOD FOR PREPARING SUBSTITUTED TRIAZOLOPYRIDINES Bayer Pharma Aktiengesellschaft (DE) 2015-05-20 EP claimed
WO-2014009219-A1 METHOD FOR PREPARING SUBSTITUTED TRIAZOLOPYRIDINES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2014-01-16 WO claimed
CN-122059959-A Synthesis method and application of pyrrolo [2,1-a ] isoquinoline compound 河南工业大学 2026-05-19 CN disclosed
CN-119930614-B Benzo [4,5] imidazo [2,1-a ] isoquinoline compound and preparation method and application thereof 烟台大学 2025-12-16 CN disclosed
CN-119930614-B Benzo [4,5] imidazo [2,1-a ] isoquinoline compound and preparation method and application thereof 烟台大学 2025-12-16 CN disclosed
CN-119930614-A Benzo [4,5] imidazo [2,1-a ] isoquinoline compound and preparation method and application thereof 烟台大学 2025-05-06 CN disclosed
CN-119930614-A Benzo [4,5] imidazo [2,1-a ] isoquinoline compound and preparation method and application thereof 烟台大学 2025-05-06 CN disclosed
CN-119930614-A Benzo [4,5] imidazo [2,1-a ] isoquinoline compound and preparation method and application thereof 烟台大学 2025-05-06 CN disclosed
CN-118930483-A Synthesis method of isoquinolone selenocyanate 新疆大学 2024-11-12 CN disclosed
WO-2014008982-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2014-01-16 WO disclosed
WO-2012163465-A1 ORGANIC ELECTROLUMINESCENCE DEVICE MERCK PATENT GMBH (DE) 2012-12-06 WO disclosed
WO-2012163465-A1 ORGANIC ELECTROLUMINESCENCE DEVICE MERCK PATENT GMBH (DE) 2012-12-06 WO disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
US-20110284799-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2011-11-24 US disclosed
WO-2010086089-A1 METAL COMPLEXES MERCK PATENT GMBH (DE) 2010-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110284799-A1 METAL COMPLEXES SOD1, AP1M1, AP3M1 KDM4E 3816/4885ALDH1A1 3721/4885LMNA 4436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.